<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8417610</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">34489662</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8417610</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnhum.2021.694919</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Characteristics of studies about VA and SA.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of studies about VA and SA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Numbers</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Intervention</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Groups</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Were HC intervened (Y/N)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Acupoints</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Data analysis</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Experimental design</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Type of SA</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="10" rowspan="1"><bold>Tactile stimulation</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">Li et al., <xref rid="B64" ref-type="bibr">2006</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 stroke/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">EA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">Y</td><td valign="top" align="left" rowspan="1" colspan="1">LI4, LI11</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(45s)-S(45s), 3 times</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" colspan="10" rowspan="1"><bold>Blunt needling</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">Napadow et al., <xref rid="B83" ref-type="bibr">2007</xref></td><td valign="top" align="left" rowspan="1" colspan="1">13 Carpal Tunnel Syndrome/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">Y</td><td valign="top" align="left" rowspan="1" colspan="1">LI4, SJ5, PC7</td><td valign="top" align="left" rowspan="1" colspan="1">FC</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 3 times/week for 3 weeks and 2 times per week for the remaining 2 weeks.</td><td valign="top" align="left" rowspan="1" colspan="1">Non-insertive cutaneous stimulation over the acupoint</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">Schaechter et al., <xref rid="B95" ref-type="bibr">2007</xref></td><td valign="top" align="left" rowspan="1" colspan="1">7 stroke</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">4 VA/3 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">N</td><td valign="top" align="left" rowspan="1" colspan="1">GLM</td><td valign="top" align="left" rowspan="1" colspan="1">RS, twice/week for 10 weeks.</td><td valign="top" align="left" rowspan="1" colspan="1">Streitberger needle</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">Chae et al., <xref rid="B10" ref-type="bibr">2009</xref></td><td valign="top" align="left" rowspan="1" colspan="1">10 Parkinson's Diseases/10 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/covert placebo/overt placebo</td><td valign="top" align="left" rowspan="1" colspan="1">N</td><td valign="top" align="left" rowspan="1" colspan="1">Left GB34</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, R(2min)-S(1min), 3 times</td><td valign="top" align="left" rowspan="1" colspan="1">Park needle</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">Chen et al., <xref rid="B15" ref-type="bibr">2015</xref></td><td valign="top" align="left" rowspan="1" colspan="1">30 knee osteoarthritis</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">10 high dose VA/10 low dose VA/10 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">ST35 and Xi yan (extra point), GB34, SP9, GB39 and SP6</td><td valign="top" align="left" rowspan="1" colspan="1">FC, left posterior medial prefrontal cortex (pMPFC), Cortical thickness analysis</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 6 acupuncture treatment sessions in 1 month (twice/week for the first 2 weeks, once/week for the last 2 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">Non-acupoints, Streitberger needle</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">Hashmi et al., <xref rid="B44" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">40 knee osteoarthritis</td><td valign="top" align="left" rowspan="1" colspan="1">EA</td><td valign="top" align="left" rowspan="1" colspan="1">20 VA/20 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LI3 and LI4</td><td valign="top" align="left" rowspan="1" colspan="1">Graph-theoretic metrics of network topology</td><td valign="top" align="left" rowspan="1" colspan="1">RS (real or sham acupuncture), lasted 25 min.</td><td valign="top" align="left" rowspan="1" colspan="1">Streitberger needle</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">Gollub et al., <xref rid="B37" ref-type="bibr">2018</xref></td><td valign="top" align="left" rowspan="1" colspan="1">43 knee osteoarthritis</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">21 MA/22 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Right Liv3 and LI4</td><td valign="top" align="left" rowspan="1" colspan="1">ReHo</td><td valign="top" align="left" rowspan="1" colspan="1">RS, five times/week, for 4 consecutive weeks.</td><td valign="top" align="left" rowspan="1" colspan="1">Streiberger needle</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">Chu et al., <xref rid="B19" ref-type="bibr">2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">30 irritable bowel syndrome</td><td valign="top" align="left" rowspan="1" colspan="1">EA</td><td valign="top" align="left" rowspan="1" colspan="1">15 EA/15 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Bilateral ST36, ST37 and SP6</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, 30 min EA</td><td valign="top" align="left" rowspan="1" colspan="1">Foam cubes</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">Yeo et al., <xref rid="B131" ref-type="bibr">2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 Parkinson's Disease/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">Y</td><td valign="top" align="left" rowspan="1" colspan="1">Right GB34</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">R(4min)-sham(S(1min)-R(1min-S(1min)-R(1min))-R(4min)-T1(10min)-verm(S(1min)-R(1min)-S(1min)-R(1min)-R(4min)</td><td valign="top" align="left" rowspan="1" colspan="1">The blunt type needle was not inserted into the skin</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">Yeo et al., <xref rid="B130" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 Parkinson's disease/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">Y</td><td valign="top" align="left" rowspan="1" colspan="1">GB34</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, SA: R(60s)-S(60s)-R(60s)-S(60s)-R(60s)-structural images(15min); then RA: R(60s)-S(60s)-R(60s)-S(60s)-R(60s)</td><td valign="top" align="left" rowspan="1" colspan="1">Park needle</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">Wang et al., <xref rid="B117" ref-type="bibr">2016b</xref></td><td valign="top" align="left" rowspan="1" colspan="1">46 depression</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">22 MA and fluoxetine/24 SA and fluoxetine</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">RN12, RN10, RN6, RN4, KL 17, ST24, and Qipang.</td><td valign="top" align="left" rowspan="1" colspan="1">FC, bilateral amygdala as the seed region</td><td valign="top" align="left" rowspan="1" colspan="1">RS, once a day for the first 3 days and subsequently once every 3 days for the remainder of the 8-week trial.</td><td valign="top" align="left" rowspan="1" colspan="1">Short plastic tubes</td></tr><tr><td valign="top" align="left" colspan="10" rowspan="1"><bold>Needling at non-acupuncture points in close proximity to acupuncture points</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">Huang et al., <xref rid="B50" ref-type="bibr">2011</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 ischemic stroke</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">6 VA/6 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">SJ5</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, S(30s)-R(30sn), 6 times</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">Liu et al., <xref rid="B76" ref-type="bibr">2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">41 myopia</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">11 VA and TI/ 11 VA and NI/10 SA and TI/9 SA and NI</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LR3</td><td valign="top" align="left" rowspan="1" colspan="1">GLM</td><td valign="top" align="left" rowspan="1" colspan="1">RS, R(186s)-S(180s)</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">Maeda et al., <xref rid="B80" ref-type="bibr">2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">59 carpal tunnel syndrome</td><td valign="top" align="left" rowspan="1" colspan="1">EA</td><td valign="top" align="left" rowspan="1" colspan="1">22 local VA/18 distal VA/19 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Local VA: PC7, SJ5; distal VA: SP-6, LV-4; SA: SH1 and SH2.</td><td valign="top" align="left" rowspan="1" colspan="1">GLM</td><td valign="top" align="left" rowspan="1" colspan="1">RS, event-related/2-s stimulation events with randomized interstimulus interval (ISI), 6–12 s, and total scan time 5 min and 6 s</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">Kang et al., <xref rid="B52" ref-type="bibr">2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">25 smoke</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">12 VA/13 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Left HT7</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, S(60s)-R(60s), 3 times</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">16</td><td valign="top" align="left" rowspan="1" colspan="1">Qi et al., <xref rid="B88" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">16 ischemic stroke</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">8 VA/8 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">SJ5</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, R(30s)-S(30s), total 6min6s</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">17</td><td valign="top" align="left" rowspan="1" colspan="1">Zhao et al., <xref rid="B142" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">40 migraine</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">20 active point/20 inactive point</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Active point: bilateral SJ5,GB20, GB34, and GB40 inactive point: bilateral SJ22, PC7, GB37, and SP3</td><td valign="top" align="left" rowspan="1" colspan="1">ReHo</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 4 times/week for 30 min each for 8 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">Chen et al., <xref rid="B13" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">6 ischemic stroke</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">SJ5</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, R(5 min)-SAstimulus(6 min30s)-R(6mmin2s)-VA(6 min30 s).</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">Zhu et al., <xref rid="B147" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">28 irritable bowel syndromes</td><td valign="top" align="left" rowspan="1" colspan="1">Mox</td><td valign="top" align="left" rowspan="1" colspan="1">15 VA/13 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">ST25, RN6, and RN12</td><td valign="top" align="left" rowspan="1" colspan="1">ICA</td><td valign="top" align="left" rowspan="1" colspan="1">RS, three times/week for 4 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">2 cm in diameter, 1.14 g in weight</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">von Deneen et al., <xref rid="B114" ref-type="bibr">2015</xref></td><td valign="top" align="left" rowspan="1" colspan="1">19 overweight</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">10 MA/9 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Bilateral ST 36 and SP 9</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block, R(5 min)-S(21min)-S(1min)-R(7 min) anatomical scan -(9 min) postscan</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">21</td><td valign="top" align="left" rowspan="1" colspan="1">Egorova et al., <xref rid="B27" ref-type="bibr">2015</xref></td><td valign="top" align="left" rowspan="1" colspan="1">41 knee osteoarthritis</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">6 acupoints/2 acupoints/SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">2 acupoint: ST35 and Xi yan (extra point) and 6 acupoints: additionally, at GB34, SP9, GB39 and SP6</td><td valign="top" align="left" rowspan="1" colspan="1">FC, periaqueductal gray (PAG) as the seed</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 6 times 25 min acupuncture sessions in 1 month</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">22</td><td valign="top" align="left" rowspan="1" colspan="1">Li et al., <xref rid="B71" ref-type="bibr">2016</xref></td><td valign="top" align="left" rowspan="1" colspan="1">62 migraine/46 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">11 VA1/11 VA2/13 VA3/11 SA/16 WT</td><td valign="top" align="left" rowspan="1" colspan="1">N</td><td valign="top" align="left" rowspan="1" colspan="1">VA1: GB34, GB40 and SJ5; VA2: GB33, GB42 and SJ8; VA3: ST36, ST42 -and L16; SA: NAP1, NAP2 and NAP3</td><td valign="top" align="left" rowspan="1" colspan="1">FC, periaqueductal gray (PAG) as the seed region</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 30 min, 5 times/week, 4 weeks.</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">23</td><td valign="top" align="left" rowspan="1" colspan="1">Zheng et al., <xref rid="B144" ref-type="bibr">2016</xref></td><td valign="top" align="left" rowspan="1" colspan="1">28 hypertension</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">14 MA/14 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LR3</td><td valign="top" align="left" rowspan="1" colspan="1">FC, hypothalamus as the seed</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 30 min, three times/week for 2 week</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">24</td><td valign="top" align="left" rowspan="1" colspan="1">Tan et al., <xref rid="B109" ref-type="bibr">2017</xref></td><td valign="top" align="left" rowspan="1" colspan="1">32 mild cognitive impairment</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">16 MA/16 SA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">EX-HN1, EX-HN3, PC6, KI3, ST40, and LR3</td><td valign="top" align="left" rowspan="1" colspan="1">FC, pregenual ACC, sub-ACC, MTL-hippocampus, IPL, and anterior insula as the seed region</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 5 times/week, for 4 consecutive weeks.</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">25</td><td valign="top" align="left" rowspan="1" colspan="1">Li et al., <xref rid="B70" ref-type="bibr">2018</xref></td><td valign="top" align="left" rowspan="1" colspan="1">35 Parkinson's disease</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">14 MA/11 SA/10 WT</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">DU20, bilateral GB20, and the Chorea-Tremor Controlled Zone</td><td valign="top" align="left" rowspan="1" colspan="1">DC,ReHo,ALFF</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 30 min, 2 times/week, for 12 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">26</td><td valign="top" align="left" rowspan="1" colspan="1">Wang et al., <xref rid="B116" ref-type="bibr">2020</xref></td><td valign="top" align="left" rowspan="1" colspan="1">45 primary insomnia</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">15 S-Acu/15 M-Acu/15 N-Acu</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">S-Acu: bilateral HT7; M-Acu: combination of bilateral HT-7, bilateral SP6 and single DU20; N-Acu: sham point</td><td valign="top" align="left" rowspan="1" colspan="1">fALFF</td><td valign="top" align="left" rowspan="1" colspan="1">RS, 30 min, 5 times/week, for 5 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">/</td></tr></tbody></table><table-wrap-foot><p><italic>ACC, anterior cingulate cortex; DC, degree centrality; EA, Electroacupuncture; fALFF, fractional amplitude of low-frequency fluctuations; FC, functional connectivity analysis; GLM, general linear model; HC, health controls; ICA, independent component analysis; MA, manual acupuncture; M, multiple; /, irrelevant; NAP, non-acupoint; NI, non-treatment instruction; N, no; NRER, non-repeated event-related; RS, resting state; ReHo, regional homogeneity; SA: sham acupuncture; S, single; TI, treatment instruction; WT, waiting list; VA, verum acupuncture; Y, yes; Acupoints: BL23, Shenshu; BL25, Dachangshu; BL40, Weizhong; BL62, Shenmai; BL26, Guanyuanshu; BL36, Chengfu; BL54, Zhibian; BL60, Kunlun; BL58, Feiyang; BL27, Xiaochangshu; BL37, Yinmen; DU3, Yaoyangguan; DU20, Baihui; DU23, Shangxing; DU29, Yintang; EX-HN5,Taiyang; EX-HN1, Sishenchong; GB8, Shuaigu; GB30, Huantiao; GB31, Fengshi; GB33,Xiyangguan; GB39, Xuanzhong; GB40, Qiuxu; GB41, Zulinqi; HT3, Shaohai; HT5, Tongli; HT7, Shenmen; KI3, Taixi; LI3, Sanjian; LI4, Hegu; LI6, Pianli; LI7, Lieque; LR8, Ququan; LR14,Jimen; LR3, Taichong; PC6, Neiguan; PC7, Daling; PC8, Laogong; RN4, Guanyuan; RN6,Qihai; RN10, Xiawan; RN12, Zhongwan;RN14, Juque; SJ6, Zhigou; SJ5, Waiguan; SJ8, Sanyangluo; SJ22, Erheliao; SJ23, Sizhukong; SP6, Sanyinjiao; SP8, Diji; SP9, Yinlingquan; SP3, Taibai; SP14, Fujie; SP11, Jimen; SP13, Fushe; SP15, Daheng; ST6, Jiache; ST9, Renying; ST21,Liangmen; ST24, Huaroumen; ST25, Tianshu; ST26, Wailing; ST27, Daju; ST35, Dubi; ST36, Zusanli; ST37, Shangjuxu; ST38, Tiaokou; ST39, Xiajuxu; ST40, Fenglong; ST42, Chongyang; ST44, Neiting</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Characteristics of studies about VA and SA.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Numbers</th><th valign="top" align="left">References</th><th valign="top" align="left">Subjects</th><th valign="top" align="left">Intervention</th><th valign="top" align="left">Groups</th><th valign="top" align="left">Were HC intervened (Y/N)</th><th valign="top" align="left">Acupoints</th><th valign="top" align="left">Data analysis</th><th valign="top" align="left">Experimental design</th><th valign="top" align="left">Type of SA</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="10">Tactile stimulation</td></tr><tr><td valign="top" align="left">1</td><td valign="top" align="left">Li et al., ???</td><td valign="top" align="left">12 stroke/12 HC</td><td valign="top" align="left">EA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">Y</td><td valign="top" align="left">LI4, LI11</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/R(45s)-S(45s), 3 times</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left" colspan="10">Blunt needling</td></tr><tr><td valign="top" align="left">2</td><td valign="top" align="left">Napadow et al., ???</td><td valign="top" align="left">13 Carpal Tunnel Syndrome/12 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">Y</td><td valign="top" align="left">LI4, SJ5, PC7</td><td valign="top" align="left">FC</td><td valign="top" align="left">RS, 3 times/week for 3 weeks and 2 times per week for the remaining 2 weeks.</td><td valign="top" align="left">Non-insertive cutaneous stimulation over the acupoint</td></tr><tr><td valign="top" align="left">3</td><td valign="top" align="left">Schaechter et al., ???</td><td valign="top" align="left">7 stroke</td><td valign="top" align="left">MA</td><td valign="top" align="left">4 VA/3 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">N</td><td valign="top" align="left">GLM</td><td valign="top" align="left">RS, twice/week for 10 weeks.</td><td valign="top" align="left">Streitberger needle</td></tr><tr><td valign="top" align="left">4</td><td valign="top" align="left">Chae et al., ???</td><td valign="top" align="left">10 Parkinson's Diseases/10 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/covert placebo/overt placebo</td><td valign="top" align="left">N</td><td valign="top" align="left">Left GB34</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, R(2min)-S(1min), 3 times</td><td valign="top" align="left">Park needle</td></tr><tr><td valign="top" align="left">5</td><td valign="top" align="left">Chen et al., ???</td><td valign="top" align="left">30 knee osteoarthritis</td><td valign="top" align="left">MA</td><td valign="top" align="left">10 high dose VA/10 low dose VA/10 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">ST35 and Xi yan (extra point), GB34, SP9, GB39 and SP6</td><td valign="top" align="left">FC, left posterior medial prefrontal cortex (pMPFC), Cortical thickness analysis</td><td valign="top" align="left">RS, 6 acupuncture treatment sessions in 1 month (twice/week for the first 2 weeks, once/week for the last 2 weeks</td><td valign="top" align="left">Non-acupoints, Streitberger needle</td></tr><tr><td valign="top" align="left">5</td><td valign="top" align="left">Hashmi et al., ???</td><td valign="top" align="left">40 knee osteoarthritis</td><td valign="top" align="left">EA</td><td valign="top" align="left">20 VA/20 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">LI3 and LI4</td><td valign="top" align="left">Graph-theoretic metrics of network topology</td><td valign="top" align="left">RS (real or sham acupuncture), lasted 25 min.</td><td valign="top" align="left">Streitberger needle</td></tr><tr><td valign="top" align="left">7</td><td valign="top" align="left">Gollub et al., ???</td><td valign="top" align="left">43 knee osteoarthritis</td><td valign="top" align="left">MA</td><td valign="top" align="left">21 MA/22 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">Right Liv3 and LI4</td><td valign="top" align="left">ReHo</td><td valign="top" align="left">RS, five times/week, for 4 consecutive weeks.</td><td valign="top" align="left">Streiberger needle</td></tr><tr><td valign="top" align="left">8</td><td valign="top" align="left">Chu et al., ???</td><td valign="top" align="left">30 irritable bowel syndrome</td><td valign="top" align="left">EA</td><td valign="top" align="left">15 EA/15 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">Bilateral ST36, ST37 and SP6</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, 30 min EA</td><td valign="top" align="left">Foam cubes</td></tr><tr><td valign="top" align="left">9</td><td valign="top" align="left">Yeo et al., ???</td><td valign="top" align="left">12 Parkinson's Disease/12 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">Y</td><td valign="top" align="left">Right GB34</td><td valign="top" align="left">SPM</td><td valign="top" align="left">R(4min)-sham(S(1min)-R(1min-S(1min)-R(1min))-R(4min)-T1(10min)-verm(S(1min)-R(1min)-S(1min)-R(1min)-R(4min)</td><td valign="top" align="left">The blunt type needle was not inserted into the skin</td></tr><tr><td valign="top" align="left">10</td><td valign="top" align="left">Yeo et al., ???</td><td valign="top" align="left">12 Parkinson's disease/12 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">Y</td><td valign="top" align="left">GB34</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, SA: R(60s)-S(60s)-R(60s)-S(60s)-R(60s)-structural images(15min); then RA: R(60s)-S(60s)-R(60s)-S(60s)-R(60s)</td><td valign="top" align="left">Park needle</td></tr><tr><td valign="top" align="left">11</td><td valign="top" align="left">Wang et al., ???</td><td valign="top" align="left">46 depression</td><td valign="top" align="left">MA</td><td valign="top" align="left">22 MA and fluoxetine/24 SA and fluoxetine</td><td valign="top" align="left">/</td><td valign="top" align="left">RN12, RN10, RN6, RN4, KL 17, ST24, and Qipang.</td><td valign="top" align="left">FC, bilateral amygdala as the seed region</td><td valign="top" align="left">RS, once a day for the first 3 days and subsequently once every 3 days for the remainder of the 8-week trial.</td><td valign="top" align="left">Short plastic tubes</td></tr><tr><td valign="top" align="left" colspan="10">Needling at non-acupuncture points in close proximity to acupuncture points</td></tr><tr><td valign="top" align="left">12</td><td valign="top" align="left">Huang et al., ???</td><td valign="top" align="left">12 ischemic stroke</td><td valign="top" align="left">MA</td><td valign="top" align="left">6 VA/6 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">SJ5</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, S(30s)-R(30sn), 6 times</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">13</td><td valign="top" align="left">Liu et al., ???</td><td valign="top" align="left">41 myopia</td><td valign="top" align="left">MA</td><td valign="top" align="left">11 VA and TI/ 11 VA and NI/10 SA and TI/9 SA and NI</td><td valign="top" align="left">/</td><td valign="top" align="left">LR3</td><td valign="top" align="left">GLM</td><td valign="top" align="left">RS, R(186s)-S(180s)</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">14</td><td valign="top" align="left">Maeda et al., ???</td><td valign="top" align="left">59 carpal tunnel syndrome</td><td valign="top" align="left">EA</td><td valign="top" align="left">22 local VA/18 distal VA/19 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">Local VA: PC7, SJ5; distal VA: SP-6, LV-4; SA: SH1 and SH2.</td><td valign="top" align="left">GLM</td><td valign="top" align="left">RS, event-related/2-s stimulation events with randomized interstimulus interval (ISI), 6–12 s, and total scan time 5 min and 6 s</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">15</td><td valign="top" align="left">Kang et al., ???</td><td valign="top" align="left">25 smoke</td><td valign="top" align="left">MA</td><td valign="top" align="left">12 VA/13 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">Left HT7</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, S(60s)-R(60s), 3 times</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">16</td><td valign="top" align="left">Qi et al., ???</td><td valign="top" align="left">16 ischemic stroke</td><td valign="top" align="left">MA</td><td valign="top" align="left">8 VA/8 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">SJ5</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, R(30s)-S(30s), total 6min6s</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">17</td><td valign="top" align="left">Zhao et al., ???</td><td valign="top" align="left">40 migraine</td><td valign="top" align="left">MA</td><td valign="top" align="left">20 active point/20 inactive point</td><td valign="top" align="left">/</td><td valign="top" align="left">Active point: bilateral SJ5,GB20, GB34, and GB40 inactive point: bilateral SJ22, PC7, GB37, and SP3</td><td valign="top" align="left">ReHo</td><td valign="top" align="left">RS, 4 times/week for 30 min each for 8 weeks</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">18</td><td valign="top" align="left">Chen et al., ???</td><td valign="top" align="left">6 ischemic stroke</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">/</td><td valign="top" align="left">SJ5</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, R(5 min)-SAstimulus(6 min30s)-R(6mmin2s)-VA(6 min30 s).</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">19</td><td valign="top" align="left">Zhu et al., ???</td><td valign="top" align="left">28 irritable bowel syndromes</td><td valign="top" align="left">Mox</td><td valign="top" align="left">15 VA/13 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">ST25, RN6, and RN12</td><td valign="top" align="left">ICA</td><td valign="top" align="left">RS, three times/week for 4 weeks</td><td valign="top" align="left">2 cm in diameter, 1.14 g in weight</td></tr><tr><td valign="top" align="left">20</td><td valign="top" align="left">von Deneen et al., ???</td><td valign="top" align="left">19 overweight</td><td valign="top" align="left">MA</td><td valign="top" align="left">10 MA/9 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">Bilateral ST 36 and SP 9</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block, R(5 min)-S(21min)-S(1min)-R(7 min) anatomical scan -(9 min) postscan</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">21</td><td valign="top" align="left">Egorova et al., ???</td><td valign="top" align="left">41 knee osteoarthritis</td><td valign="top" align="left">MA</td><td valign="top" align="left">6 acupoints/2 acupoints/SA</td><td valign="top" align="left">/</td><td valign="top" align="left">2 acupoint: ST35 and Xi yan (extra point) and 6 acupoints: additionally, at GB34, SP9, GB39 and SP6</td><td valign="top" align="left">FC, periaqueductal gray (PAG) as the seed</td><td valign="top" align="left">RS, 6 times 25 min acupuncture sessions in 1 month</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">22</td><td valign="top" align="left">Li et al., ???</td><td valign="top" align="left">62 migraine/46 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">11 VA1/11 VA2/13 VA3/11 SA/16 WT</td><td valign="top" align="left">N</td><td valign="top" align="left">VA1: GB34, GB40 and SJ5; VA2: GB33, GB42 and SJ8; VA3: ST36, ST42 -and L16; SA: NAP1, NAP2 and NAP3</td><td valign="top" align="left">FC, periaqueductal gray (PAG) as the seed region</td><td valign="top" align="left">RS, 30 min, 5 times/week, 4 weeks.</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">23</td><td valign="top" align="left">Zheng et al., ???</td><td valign="top" align="left">28 hypertension</td><td valign="top" align="left">MA</td><td valign="top" align="left">14 MA/14 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">LR3</td><td valign="top" align="left">FC, hypothalamus as the seed</td><td valign="top" align="left">RS, 30 min, three times/week for 2 week</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">24</td><td valign="top" align="left">Tan et al., ???</td><td valign="top" align="left">32 mild cognitive impairment</td><td valign="top" align="left">MA</td><td valign="top" align="left">16 MA/16 SA</td><td valign="top" align="left">/</td><td valign="top" align="left">EX-HN1, EX-HN3, PC6, KI3, ST40, and LR3</td><td valign="top" align="left">FC, pregenual ACC, sub-ACC, MTL-hippocampus, IPL, and anterior insula as the seed region</td><td valign="top" align="left">RS, 5 times/week, for 4 consecutive weeks.</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">25</td><td valign="top" align="left">Li et al., ???</td><td valign="top" align="left">35 Parkinson's disease</td><td valign="top" align="left">MA</td><td valign="top" align="left">14 MA/11 SA/10 WT</td><td valign="top" align="left">/</td><td valign="top" align="left">DU20, bilateral GB20, and the Chorea-Tremor Controlled Zone</td><td valign="top" align="left">DC,ReHo,ALFF</td><td valign="top" align="left">RS, 30 min, 2 times/week, for 12 weeks</td><td valign="top" align="left">/</td></tr><tr><td valign="top" align="left">26</td><td valign="top" align="left">Wang et al., ???</td><td valign="top" align="left">45 primary insomnia</td><td valign="top" align="left">MA</td><td valign="top" align="left">15 S-Acu/15 M-Acu/15 N-Acu</td><td valign="top" align="left">/</td><td valign="top" align="left">S-Acu: bilateral HT7; M-Acu: combination of bilateral HT-7, bilateral SP6 and single DU20; N-Acu: sham point</td><td valign="top" align="left">fALFF</td><td valign="top" align="left">RS, 30 min, 5 times/week, for 5 weeks</td><td valign="top" align="left">/</td></tr></tbody></table></div>ACC, anterior cingulate cortex; DC, degree centrality; EA, Electroacupuncture; fALFF, fractional amplitude of low-frequency fluctuations; FC, functional connectivity analysis; GLM, general linear model; HC, health controls; ICA, independent component analysis; MA, manual acupuncture; M, multiple; /, irrelevant; NAP, non-acupoint; NI, non-treatment instruction; N, no; NRER, non-repeated event-related; RS, resting state; ReHo, regional homogeneity; SA: sham acupuncture; S, single; TI, treatment instruction; WT, waiting list; VA, verum acupuncture; Y, yes; Acupoints: BL23, Shenshu; BL25, Dachangshu; BL40, Weizhong; BL62, Shenmai; BL26, Guanyuanshu; BL36, Chengfu; BL54, Zhibian; BL60, Kunlun; BL58, Feiyang; BL27, Xiaochangshu; BL37, Yinmen; DU3, Yaoyangguan; DU20, Baihui; DU23, Shangxing; DU29, Yintang; EX-HN5,Taiyang; EX-HN1, Sishenchong; GB8, Shuaigu; GB30, Huantiao; GB31, Fengshi; GB33,Xiyangguan; GB39, Xuanzhong; GB40, Qiuxu; GB41, Zulinqi; HT3, Shaohai; HT5, Tongli; HT7, Shenmen; KI3, Taixi; LI3, Sanjian; LI4, Hegu; LI6, Pianli; LI7, Lieque; LR8, Ququan; LR14,Jimen; LR3, Taichong; PC6, Neiguan; PC7, Daling; PC8, Laogong; RN4, Guanyuan; RN6,Qihai; RN10, Xiawan; RN12, Zhongwan;RN14, Juque; SJ6, Zhigou; SJ5, Waiguan; SJ8, Sanyangluo; SJ22, Erheliao; SJ23, Sizhukong; SP6, Sanyinjiao; SP8, Diji; SP9, Yinlingquan; SP3, Taibai; SP14, Fujie; SP11, Jimen; SP13, Fushe; SP15, Daheng; ST6, Jiache; ST9, Renying; ST21,Liangmen; ST24, Huaroumen; ST25, Tianshu; ST26, Wailing; ST27, Daju; ST35, Dubi; ST36, Zusanli; ST37, Shangjuxu; ST38, Tiaokou; ST39, Xiajuxu; ST40, Fenglong; ST42, Chongyang; ST44, Neiting.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Characteristics of studies about patients and HC.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Characteristics of studies about patients and HC.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Numbers</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Intervention</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Groups</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Acupoints</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Data analysis</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Experimental design</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Results</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">Li et al., <xref rid="B64" ref-type="bibr">2006</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 stroke/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">EA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LI4 and LI11</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(45s)-S(45s), 3 times</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, patients showed greater activation in the somatosensory cortex with both the tactile task and the acupoint stimulation</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">Wu et al., <xref rid="B123" ref-type="bibr">2008</xref></td><td valign="top" align="left" rowspan="1" colspan="1">11 spastic cerebral palsy/10 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Left LI3</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/S(1min)-R(1min),3 times</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, the children with cerebral showed significant decrease in the frontal lobe contralateral temporal lobe, and parahippocampal gyrus; and signal increase in bilateral occipitallobe and ipsilateral insula.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">Li and Yang, <xref rid="B65" ref-type="bibr">2011</xref></td><td valign="top" align="left" rowspan="1" colspan="1">7 aphasia stroke/14 HC</td><td valign="top" align="left" rowspan="1" colspan="1">EA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">SJ 8</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(45s)-S(45s), 3 times</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, patients showed significant activation in the opercular, triangular, or insula.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">Feng et al., <xref rid="B30" ref-type="bibr">2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 mild cognitive impairment/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">DA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">KI3</td><td valign="top" align="left" rowspan="1" colspan="1">FC</td><td valign="top" align="left" rowspan="1" colspan="1">NRER/R(1min)-S(DA/SA)(2min)-R(6min)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, mild cognitive impairment patients showed enhanced the correlations related with the temporal regions.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">Yeo et al., <xref rid="B131" ref-type="bibr">2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 Parkinson's Disease/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">Right GB34</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">R(4min)-sham(S(1min)-R(1min-S(1min)-R(1min)-R(4min)-T1(10min)-verm(S(1min)-R(1min)-S(1min)-R(1min)-R(4min)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to the HC, patients with Parkinson's disease showed a significantly higher signal increase in the thalamus</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">Chen J. et al., <xref rid="B12" ref-type="bibr">2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">10 ischemic stroke/6 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">SJ5</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(30s)-S(30s), 6 times</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to the HC, stroke patients showed enhanced activation in the left Brodmann areas, hypothalamus, and the ventral posterolateral nucleus, and the right BA4, 6, 7, 18, 19, and 32.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">Cho et al., <xref rid="B16" ref-type="bibr">2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">11 stroke/10 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LI11 and ST36</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(30s)-S(30s), 3 times</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to the HC, stroke group showed less brain activation.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">Zhou et al., <xref rid="B145" ref-type="bibr">2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">24 functional diarrhea/24 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">ST25</td><td valign="top" align="left" rowspan="1" colspan="1">ReHo and FC</td><td valign="top" align="left" rowspan="1" colspan="1">RS/2 weeks, 5 sessions per week</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, functional diarrhea was more effective in clinical outcome and had more extensive cerebral ReHo changes.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">Quah-Smith et al., <xref rid="B91" ref-type="bibr">2013</xref></td><td valign="top" align="left" rowspan="1" colspan="1">10 depression/10 HC</td><td valign="top" align="left" rowspan="1" colspan="1">LA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LR14, LR8, RN14, and HT7</td><td valign="top" align="left" rowspan="1" colspan="1">ICA</td><td valign="top" align="left" rowspan="1" colspan="1">Task/block(2s delay-R(2s)-s(20s))/8 times, 8 session</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, depressed participants had wider posterior default mode network modulation at the parieto–temporal–limbic cortices.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1">Zhang et al., <xref rid="B140" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">8 ischemic stroke/10 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">DA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">GB34</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">NRER/R(1min)-S(1min)-R(8min)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, stroke patients showed the enhanced interregional interactions between the anterior cingulate cortex (ACC) and posterior cingulate cortex (PCC).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">Xie et al., <xref rid="B126" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">9 stable recovery stroke/8 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">GB34</td><td valign="top" align="left" rowspan="1" colspan="1">GLM and GCA</td><td valign="top" align="left" rowspan="1" colspan="1">NRER/R(1min)-S(1min)-R(8min)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, stroke patients showed specific modulations of motor-related network in stroke patients.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1">He et al., <xref rid="B46" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">28 Bell's palsy/20 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">18 early group/21 late group/19 recovered group</td><td valign="top" align="left" rowspan="1" colspan="1">LI4 on the contralateral side of paresis</td><td valign="top" align="left" rowspan="1" colspan="1">FC, SI as the seed region</td><td valign="top" align="left" rowspan="1" colspan="1">RS/10 min, three times a week</td><td valign="top" align="left" rowspan="1" colspan="1">No significant changes in HC, Bell's pals patients showed significant connectivity changes in the SI region.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1">Wang et al., <xref rid="B118" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">14 Alzheimer's Disease/14 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Bilateral LR3 and LI4</td><td valign="top" align="left" rowspan="1" colspan="1">FC, bilateral hippocampus as the seed region</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(3min)-S(3min)-R(10min)</td><td valign="top" align="left" rowspan="1" colspan="1">No significant changes in HC, Alzheimer's Disease(AD) patients showed increased FC in right hippocampus and right STG.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1">Liang et al., <xref rid="B75" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">9 Alzheimer's Disease/11 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Right Liv3 and LI4</td><td valign="top" align="left" rowspan="1" colspan="1">ICA</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(3min)-S(3min)-R(10min)</td><td valign="top" align="left" rowspan="1" colspan="1">All the brain activation modulated by acupuncture were specifically for AD but not for HC.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">Li et al., <xref rid="B68" ref-type="bibr">2014d</xref></td><td valign="top" align="left" rowspan="1" colspan="1">24 functional dyspepsia/24 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">Right ST36</td><td valign="top" align="left" rowspan="1" colspan="1">GLM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/R(1min)-S(1min)-R(1min)-S(1min)-R(1min)-S(1min)-R(1min)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared to HC, acupuncture evoked pronounced changes, especially in the homeostatic afferent processing network of FD patients.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">16</td><td valign="top" align="left" rowspan="1" colspan="1">Yeo et al., <xref rid="B130" ref-type="bibr">2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">12 Parkinson's disease/12 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">VA/SA</td><td valign="top" align="left" rowspan="1" colspan="1">GB34</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/SA:R(60s)-S(60s)-R(60s)-S(60s)-R(60s)-structural images(15min); then RA:R(60s)-S(60s)-R(60s)-S(60s)-R(60s)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared with HC, patients with PD showed significantly higher brain activity in the prefrontal cortex and precentral gyrus, especially visible in the left hemisphere. which are all known to be affected by PD</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">17</td><td valign="top" align="left" rowspan="1" colspan="1">Gao et al., <xref rid="B33" ref-type="bibr">2015</xref></td><td valign="top" align="left" rowspan="1" colspan="1">10 ischemic stroke/10 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">ST36</td><td valign="top" align="left" rowspan="1" colspan="1">SPM</td><td valign="top" align="left" rowspan="1" colspan="1">Block/(30s)-S(30s), 6 times</td><td valign="top" align="left" rowspan="1" colspan="1">Significant regions in the HC included the prefrontal cortex, cingulum, thalamus, and cerebellum; Significant regions in the stroke patients included the cuneus, supplementary motor area, and inferior parietal gyrus.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">18</td><td valign="top" align="left" rowspan="1" colspan="1">Wu et al., <xref rid="B121" ref-type="bibr">2015</xref></td><td valign="top" align="left" rowspan="1" colspan="1">20 Bell's Palsy/20 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">LI4</td><td valign="top" align="left" rowspan="1" colspan="1">FC, ACC as the seed region</td><td valign="top" align="left" rowspan="1" colspan="1">RS, block/R(10min)-S(10min, Rotate needles10 s every 2 min)-R(10min)</td><td valign="top" align="left" rowspan="1" colspan="1">Significant decreased connectivity of the right ACC in the early group, no significant effect on FC of bilateral ACC in HC.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">19</td><td valign="top" align="left" rowspan="1" colspan="1">Han et al., <xref rid="B42" ref-type="bibr">2019</xref></td><td valign="top" align="left" rowspan="1" colspan="1">22 poststroke motor impairment/22 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">GB34</td><td valign="top" align="left" rowspan="1" colspan="1">TBSS and FC</td><td valign="top" align="left" rowspan="1" colspan="1">NRER/R(8 min10s)-S(1min)-R(8 min10s)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared with the HC, stroke patients showed enhanced FC between the (PM)/supplementary motor area (SMA) and supramarginal gyrus (SMG).</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">Han et al., <xref rid="B43" ref-type="bibr">2020</xref></td><td valign="top" align="left" rowspan="1" colspan="1">26 ischemic stroke/21 HC</td><td valign="top" align="left" rowspan="1" colspan="1">MA</td><td valign="top" align="left" rowspan="1" colspan="1">/</td><td valign="top" align="left" rowspan="1" colspan="1">GB34</td><td valign="top" align="left" rowspan="1" colspan="1">Graph Theoretical Network Analysis</td><td valign="top" align="left" rowspan="1" colspan="1">RS/R(8min10s)-S(60s)-R(8min10s)</td><td valign="top" align="left" rowspan="1" colspan="1">Compared with the HC, the stroke patients had a decreased normalized small-worldness (σ), global efficiency (Eg), and the mean local efficiency (Eloc) of the whole-brain network in the resting state.</td></tr></tbody></table><table-wrap-foot><p><italic>LA, laser acupuncture; SI, primary somatosensory area; TBSS, tract-based spatial statistics</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Characteristics of studies about patients and HC.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Numbers</th><th valign="top" align="left">References</th><th valign="top" align="left">Subjects</th><th valign="top" align="left">Intervention</th><th valign="top" align="left">Groups</th><th valign="top" align="left">Acupoints</th><th valign="top" align="left">Data analysis</th><th valign="top" align="left">Experimental design</th><th valign="top" align="left">Results</th></tr></thead><tbody><tr><td valign="top" align="left">1</td><td valign="top" align="left">Li et al., ???</td><td valign="top" align="left">12 stroke/12 HC</td><td valign="top" align="left">EA</td><td valign="top" align="left">/</td><td valign="top" align="left">LI4 and LI11</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/R(45s)-S(45s), 3 times</td><td valign="top" align="left">Compared to HC, patients showed greater activation in the somatosensory cortex with both the tactile task and the acupoint stimulation</td></tr><tr><td valign="top" align="left">2</td><td valign="top" align="left">Wu et al., ???</td><td valign="top" align="left">11 spastic cerebral palsy/10 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">Left LI3</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/S(1min)-R(1min),3 times</td><td valign="top" align="left">Compared to HC, the children with cerebral showed significant decrease in the frontal lobe contralateral temporal lobe, and parahippocampal gyrus; and signal increase in bilateral occipitallobe and ipsilateral insula.</td></tr><tr><td valign="top" align="left">3</td><td valign="top" align="left">Li and Yang, ???</td><td valign="top" align="left">7 aphasia stroke/14 HC</td><td valign="top" align="left">EA</td><td valign="top" align="left">/</td><td valign="top" align="left">SJ 8</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/R(45s)-S(45s), 3 times</td><td valign="top" align="left">Compared to HC, patients showed significant activation in the opercular, triangular, or insula.</td></tr><tr><td valign="top" align="left">4</td><td valign="top" align="left">Feng et al., ???</td><td valign="top" align="left">12 mild cognitive impairment/12 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">DA/SA</td><td valign="top" align="left">KI3</td><td valign="top" align="left">FC</td><td valign="top" align="left">NRER/R(1min)-S(DA/SA)(2min)-R(6min)</td><td valign="top" align="left">Compared to HC, mild cognitive impairment patients showed enhanced the correlations related with the temporal regions.</td></tr><tr><td valign="top" align="left">5</td><td valign="top" align="left">Yeo et al., ???</td><td valign="top" align="left">12 Parkinson's Disease/12 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">Right GB34</td><td valign="top" align="left">SPM</td><td valign="top" align="left">R(4min)-sham(S(1min)-R(1min-S(1min)-R(1min)-R(4min)-T1(10min)-verm(S(1min)-R(1min)-S(1min)-R(1min)-R(4min)</td><td valign="top" align="left">Compared to the HC, patients with Parkinson's disease showed a significantly higher signal increase in the thalamus</td></tr><tr><td valign="top" align="left">6</td><td valign="top" align="left">Chen J. et al., ???</td><td valign="top" align="left">10 ischemic stroke/6 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">SJ5</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/R(30s)-S(30s), 6 times</td><td valign="top" align="left">Compared to the HC, stroke patients showed enhanced activation in the left Brodmann areas, hypothalamus, and the ventral posterolateral nucleus, and the right BA4, 6, 7, 18, 19, and 32.</td></tr><tr><td valign="top" align="left">7</td><td valign="top" align="left">Cho et al., ???</td><td valign="top" align="left">11 stroke/10 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">LI11 and ST36</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/R(30s)-S(30s), 3 times</td><td valign="top" align="left">Compared to the HC, stroke group showed less brain activation.</td></tr><tr><td valign="top" align="left">8</td><td valign="top" align="left">Zhou et al., ???</td><td valign="top" align="left">24 functional diarrhea/24 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">ST25</td><td valign="top" align="left">ReHo and FC</td><td valign="top" align="left">RS/2 weeks, 5 sessions per week</td><td valign="top" align="left">Compared to HC, functional diarrhea was more effective in clinical outcome and had more extensive cerebral ReHo changes.</td></tr><tr><td valign="top" align="left">9</td><td valign="top" align="left">Quah-Smith et al., ???</td><td valign="top" align="left">10 depression/10 HC</td><td valign="top" align="left">LA</td><td valign="top" align="left">/</td><td valign="top" align="left">LR14, LR8, RN14, and HT7</td><td valign="top" align="left">ICA</td><td valign="top" align="left">Task/block(2s delay-R(2s)-s(20s))/8 times, 8 session</td><td valign="top" align="left">Compared to HC, depressed participants had wider posterior default mode network modulation at the parieto–temporal–limbic cortices.</td></tr><tr><td valign="top" align="left">10</td><td valign="top" align="left">Zhang et al., ???</td><td valign="top" align="left">8 ischemic stroke/10 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">DA/SA</td><td valign="top" align="left">GB34</td><td valign="top" align="left">SPM</td><td valign="top" align="left">NRER/R(1min)-S(1min)-R(8min)</td><td valign="top" align="left">Compared to HC, stroke patients showed the enhanced interregional interactions between the anterior cingulate cortex (ACC) and posterior cingulate cortex (PCC).</td></tr><tr><td valign="top" align="left">11</td><td valign="top" align="left">Xie et al., ???</td><td valign="top" align="left">9 stable recovery stroke/8 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">GB34</td><td valign="top" align="left">GLM and GCA</td><td valign="top" align="left">NRER/R(1min)-S(1min)-R(8min)</td><td valign="top" align="left">Compared to HC, stroke patients showed specific modulations of motor-related network in stroke patients.</td></tr><tr><td valign="top" align="left">12</td><td valign="top" align="left">He et al., ???</td><td valign="top" align="left">28 Bell's palsy/20 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">18 early group/21 late group/19 recovered group</td><td valign="top" align="left">LI4 on the contralateral side of paresis</td><td valign="top" align="left">FC, SI as the seed region</td><td valign="top" align="left">RS/10 min, three times a week</td><td valign="top" align="left">No significant changes in HC, Bell's pals patients showed significant connectivity changes in the SI region.</td></tr><tr><td valign="top" align="left">13</td><td valign="top" align="left">Wang et al., ???</td><td valign="top" align="left">14 Alzheimer's Disease/14 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">Bilateral LR3 and LI4</td><td valign="top" align="left">FC, bilateral hippocampus as the seed region</td><td valign="top" align="left">Block/R(3min)-S(3min)-R(10min)</td><td valign="top" align="left">No significant changes in HC, Alzheimer's Disease(AD) patients showed increased FC in right hippocampus and right STG.</td></tr><tr><td valign="top" align="left">14</td><td valign="top" align="left">Liang et al., ???</td><td valign="top" align="left">9 Alzheimer's Disease/11 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">Right Liv3 and LI4</td><td valign="top" align="left">ICA</td><td valign="top" align="left">Block/R(3min)-S(3min)-R(10min)</td><td valign="top" align="left">All the brain activation modulated by acupuncture were specifically for AD but not for HC.</td></tr><tr><td valign="top" align="left">15</td><td valign="top" align="left">Li et al., ???</td><td valign="top" align="left">24 functional dyspepsia/24 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">Right ST36</td><td valign="top" align="left">GLM</td><td valign="top" align="left">Block/R(1min)-S(1min)-R(1min)-S(1min)-R(1min)-S(1min)-R(1min)</td><td valign="top" align="left">Compared to HC, acupuncture evoked pronounced changes, especially in the homeostatic afferent processing network of FD patients.</td></tr><tr><td valign="top" align="left">16</td><td valign="top" align="left">Yeo et al., ???</td><td valign="top" align="left">12 Parkinson's disease/12 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">VA/SA</td><td valign="top" align="left">GB34</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/SA:R(60s)-S(60s)-R(60s)-S(60s)-R(60s)-structural images(15min); then RA:R(60s)-S(60s)-R(60s)-S(60s)-R(60s)</td><td valign="top" align="left">Compared with HC, patients with PD showed significantly higher brain activity in the prefrontal cortex and precentral gyrus, especially visible in the left hemisphere. which are all known to be affected by PD</td></tr><tr><td valign="top" align="left">17</td><td valign="top" align="left">Gao et al., ???</td><td valign="top" align="left">10 ischemic stroke/10 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">ST36</td><td valign="top" align="left">SPM</td><td valign="top" align="left">Block/(30s)-S(30s), 6 times</td><td valign="top" align="left">Significant regions in the HC included the prefrontal cortex, cingulum, thalamus, and cerebellum; Significant regions in the stroke patients included the cuneus, supplementary motor area, and inferior parietal gyrus.</td></tr><tr><td valign="top" align="left">18</td><td valign="top" align="left">Wu et al., ???</td><td valign="top" align="left">20 Bell's Palsy/20 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">LI4</td><td valign="top" align="left">FC, ACC as the seed region</td><td valign="top" align="left">RS, block/R(10min)-S(10min, Rotate needles10 s every 2 min)-R(10min)</td><td valign="top" align="left">Significant decreased connectivity of the right ACC in the early group, no significant effect on FC of bilateral ACC in HC.</td></tr><tr><td valign="top" align="left">19</td><td valign="top" align="left">Han et al., ???</td><td valign="top" align="left">22 poststroke motor impairment/22 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">GB34</td><td valign="top" align="left">TBSS and FC</td><td valign="top" align="left">NRER/R(8 min10s)-S(1min)-R(8 min10s)</td><td valign="top" align="left">Compared with the HC, stroke patients showed enhanced FC between the (PM)/supplementary motor area (SMA) and supramarginal gyrus (SMG).</td></tr><tr><td valign="top" align="left">20</td><td valign="top" align="left">Han et al., ???</td><td valign="top" align="left">26 ischemic stroke/21 HC</td><td valign="top" align="left">MA</td><td valign="top" align="left">/</td><td valign="top" align="left">GB34</td><td valign="top" align="left">Graph Theoretical Network Analysis</td><td valign="top" align="left">RS/R(8min10s)-S(60s)-R(8min10s)</td><td valign="top" align="left">Compared with the HC, the stroke patients had a decreased normalized small-worldness (σ), global efficiency (Eg), and the mean local efficiency (Eloc) of the whole-brain network in the resting state.</td></tr></tbody></table></div>LA, laser acupuncture; SI, primary somatosensory area; TBSS, tract-based spatial statistics.</transformed-table></extracted-table></extracted-tables-set>